Dissociation of microangiopathy and macroangiopathy in patients with type 2 diabetes

Diabetes Care

Volumn 21, Issue 9, 1998, Pages 1451-1454

  Yamamoto, Maki ^a   Egusa, Genshi ^a   Okubo, Masamichi ^a   Yamakido, Mlchio ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETIC ANGIOPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; INHERITANCE; MAJOR CLINICAL STUDY; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

EID: 3543027403     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.9.1451     Document Type: Article

References (30)

1. Lee ET, Lee VS, Kingsley RM, Lu M, Russell D, Asal NR, Wilkinson CP, Bradford RH Jr: Diabetic retinopathy in Oklahoma Indians with NIDDM: incidence and risk factors. Diabetes Care 15:1620-1627, 1992
2. Chen MS, Kao CS, Fu CC, Chen CJ, Tai TY: Incidence and progression of diabetic retinopathy among non-insulin-dependent diabetic subjects: a 4-year follow-up. Int J Epidemiol 24:787-795, 1995
3. Klein R, Klein BE, Moss SE: Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med 124:90-96, 1996
4. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
5. U.K. Prospective Diabetes Study 16: Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 44: 1249-1258, 1995
6. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28:103-117, 1995
7. Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149:1514-1520, 1989
8. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
9. Meigus JB, Singer D, Sullivan L, Dukes K, D'Agostino R, Nathan D, Wagner E, Kaplan S, Greenfield S: Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): the NIDDM Patient Research Team. Am J Med 102:38-47, 1997
10. Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hongaku H, Maeda H, Handa N, Matsumoto M, Kamada T: Prevalence of carotid atherosclerosis in diabetic patients. Diabetes Care 15:1290-1294, 1992
11. Klein BE, Davis MD, Segal P, Long JA, Harris WA, Haug GA, Magli YL, Syrjala S: Diabetic retinopathy: assessment of severity and progression. Ophthalmology 91:10-17, 1984
12. Rieckert H: Orthostatic hypotension: how to avoid it during antihypertensive therapy Am J Hypertens 9 (Suppl. 11):155S-159S, 1996
13. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC: Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340:1376-1379, 1992
14. Van den Ouweland JM, Lemkes HH, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PA, van de Kamp JJ, Maassen JA: Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1:368-371, 1992
15. Lee ET, Lee VS, Lu M, Russell D: Development of proliferate retinopathy in NIDDM: a follow-up study of American Indians in Oklahoma. Diabetes 41:359- 367, 1992
16. Chen MS, Kao CS, Chang CJ, Wu TJ, Fu CC, Chen CJ, Tai TY: Prevalence and risk factors of diabetic retinopathy among non-insulin-dependent diabetic subjects. Am J Ophthalmol 114:723-730, 1992
17. Ito H, Harano Y, Suzuki M, Hattori Y, Takeuchi M, Inada H, Inoue J, Kawamori R, Murase T, Ouchi Y, Umeda F, Nawata H, Orimo H: Risk factor analyses for macrovascular complication in nonobese NIDDM patients: Multiclinical Study for Diabetic Macro angiopathy (MSDM). Diabetes 45 (Suppl. 3):S19-S23, 1996
18. Poli A, Tremoli E, Colombo A, Sirtori M, Pignoli P, Paoletti R: Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients: a new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects. Atherosclerosis 70:253-261, 1988
19. Handa N, Matsumoto M, Maeda H, Hougaku H, Ogawa S, Fukunaga R, Yoneda S, Kimura K, Kamada T: Ultrasonic evaluation of early carotid atherosclerosis. Stroke 21:1567-1572, 1990
20. Visona A, Luisiani L, Bonanome A, Beltramello G, Confortin L, Papesso B, Costa F, Pagnan A: Wall thickening of common carotid arteries in patients affected by non-insulin-dependent diabetes mellitus: relationship to microvascular complications. Angiology 46:793-799, 1995
21. Cheta D, Dumitrescu C, Georgescu M, Cocioaba G, Lichiardopol R, Stamoran M, Ionescu-Tirgoviste C, Paunescu-Georgescu M, Mincu I: A study on the types of diabetes mellitus in first degree relatives of diabetic patients. Diabete Metab 16:11-15, 1990
22. Elbein SC, Maxwell TM, Schumacher MC: Insulin and glucose levels and prevalence of glucose intolerance in pedigrees with multiple diabetic siblings. Diabetes 40:1024-1032, 1991
23. O'Rahilly S, Turner RC: Early-onset type 2 diabetes vs maturity-onset diabetes of youth: evidence for the existence of two discrete diabetic syndromes. Diabet Med 5:224-229, 1988
24. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC: Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 33:438-443, 1990
25. Dornan TL, Ting A, McPherson CK, Peckar CO, Mann JI, Tumer RC, Morris PJ: Genetic susceptibility to the development of retinopathy in insulin-dependent diabetics. Diabetes 31:226-231, 1982
26. Baldwin RN, Mijovic C, Fletcher J, Bradwell AR, Barnett AH, Hockaday TD: Immunoglobulin heavy chain phenotypes and back-ground retinopathy in non-insulin dependent diabetics. BMJ 297:1104-1105, 1988
27. McCarthy M, Cassell P, Tran T, Mathias L, 't Hart LM, Maassen JA, Snehalatha C, Ramachandran A, Viswanathan M, Hitman GA: Evaluation of the importance of maternal history of diabetes and of mitochondrial variation in the development of NIDDM. Diabet Med 13:420-428, 1996
28. Zee RY, Lou YK, Griffiths LR, Morris BJ: Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Commun 184:9-15, 1992
29. Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, Ueda H, Rakugi H, Higaki J: Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 18:983-985, 1995
30. Nagi DK, Mansfield MW, Stickland MH, Grant PJ: Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diabet Med 12:997-1001, 1995